Wu-Tong Ju (Wutong Ju)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Mesenchymal Stem Cells

Top Venues

Nature communications

International journal of surgery (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Mei Zhao, Tianxiao Wang, Frederico Omar Gleber-Netto, Zhen Chen, Daniel J McGrail, Javier A Gomez, Wu-Tong Ju, Mayur A Gadhikar, Wencai Ma, Li Shen, Qi Wang, Ximing Tang, Sen Pathak, Maria Gabriela Raso, Jared K Burks, Shiaw-Yih Lin, Jing Wang, Asha S Multani, Curtis R Pickering, Junjie Chen, Jeffrey N Myers, Ge Zhou
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. Nature communications 15 (1) (2024)
Mei Zhao, Tianxiao Wang, Frederico Omar Gleber-Netto, Zhen Chen, Daniel J McGrail, Javier A Gomez, Wu-Tong Ju, Mayur A Gadhikar, Wencai Ma, Li Shen, Qi Wang, Ximing Tang, Sen Pathak, Maria Gabriela Raso, Jared K Burks, Shiaw-Yih Lin, Jing Wang, Asha S Multani, Curtis R Pickering, Junjie Chen, Jeffrey N Myers, Ge Zhou
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. Nature communications 15 (1) (2024)
Mei Zhao, Tianxiao Wang, Frederico Omar Gleber-Netto, Zhen Chen, Daniel J McGrail, Javier A Gomez, Wu-Tong Ju, Mayur A Gadhikar, Wencai Ma, Li Shen, Qi Wang, Ximing Tang, Sen Pathak, Maria Gabriela Raso, Jared K Burks, Shiaw-Yih Lin, Jing Wang, Asha S Multani, Curtis R Pickering, Junjie Chen, Jeffrey N Myers, Ge Zhou
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. Nature communications 15 (1) (2024)
Wu-Tong Ju, Yiyi Zhang, Ying Liu, Jing-Jing Sun, Jiang Li, Minjun Dong, Qi Sun, Wentao Shi, Tongchao Zhao, Zhihang Zhou, Yingying Huang, Xinyu Zhou, Dongwang Zhu, Shengjin Dou, Zhiyuan Zhang, Yue He, Chenping Zhang, Ronghui Xia, Guo-Pei Zhu, Laiping Zhong
Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? a retrospective cohort study. International journal of surgery (London, England) (2023)
Yingying Huang, Jingjing Sun, Jun Li, Dongwang Zhu, Minjun Dong, Shengjin Dou, Yong Tang, Wentao Shi, Qi Sun, Tongchao Zhao, Zhihang Zhou, Xinyu Zhou, Ying Liu, Jiang Li, Guopei Zhu, Ding Zhang, Yanan Chen, Qi Zhu, Wu-Tong Ju, Laiping Zhong
Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial). International journal of surgery (London, England) (2023)
Wu-Tong Ju, Rong-Hui Xia, Dong-Wang Zhu, Sheng-Jin Dou, Guo-Pei Zhu, Min-Jun Dong, Li-Zhen Wang, Qi Sun, Tong-Chao Zhao, Zhi-Hang Zhou, Si-Yuan Liang, Ying-Ying Huang, Yong Tang, Si-Cheng Wu, Jing Xia, Shi-Qing Chen, Yue-Zong Bai, Jiang Li, Qi Zhu, Lai-Ping Zhong
A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. Nature communications 13 (1) (2022)